500 patients67,039 observations150 daysLIVE

Patient P-03218

Synthetic patientONX-7 · Day 109 · 25–34 · M · baseline S20Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Unstable
Discontinuation risk
61%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S20
  2. Day 102 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 102.

Primary contributors, last 14 days
  • GI instability+16
  • Inflammatory activity+16
  • Treatment adherence-14
  • Nutritional resilience-13
  • Toxicity+8

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    61%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 86% showed improvement
    • median effect visible after 8 days

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Energy level
    Daily log
    3.1/10
    worsening · -1.3 vs previous 14 d
    Stress level
    Daily log
    6.1/10
    worsening · +1.1 vs previous 14 d
    Pessimism score
    Daily log
    5.7/10
    worsening · +0.8 vs previous 14 d
    Sleep quality
    Wearable
    7.3/100
    worsening · -6.8 vs previous 14 d
    Libido
    Daily log
    3.3/10
    worsening · -1.0 vs previous 14 d
    HRV
    Wearable
    20.5 ms
    worsening · -5.3 vs previous 14 d
    Toxicity
    Blood
    32.8/100
    worsening · +11.4 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 43 from the failing basin, 46 from restoration.

    Would help
    • GI-04 GI Support Protocol
      84% improved among 31 similar · onset 8 d · confidence 57%
    • DT-01 Dosing / Timing Recommendation
      83% improved among 12 similar · onset 5 d · confidence 68%
    • ME-01 Monitoring Escalation
      100% improved among 8 similar · onset 3 d · confidence 68%
    • More protein
      GI -3.1 next day on high-intake days · n 17
    Would not help
    • Keep alcohol low
      GI +1.7 next day on high-intake days · n 25
    • Keep fat low
      GI +1.6 next day on high-intake days · n 26
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -3.1supporter · 95%
    • Alcohol
      +1.7detractor · 76%
    • Dietary fat load
      +1.6detractor · 69%
    • Caffeine
      -1.1no signal · 36%
    • Lactose
      +0.5no signal · 19%
    • Histamine load
      0no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling 85
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
      • BloodInflammatory load index 46
      • WearableHRV 21 ms, trending down
    • Butyrate / short-chain fatty acid production 55
      • MicrobiomeButyrate capacity 29/100
      • Daily logFibre intake low in recent food logs
    • Autonomic recovery 45
      • WearableResting HR 73 bpm
      • WearableShort sleep window
    • Mucosal barrier integrity 30
      • Daily logGI symptom score 50 and rising
      • WearableSleep 4.8 h, below personal baseline
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.4 · butyrate capacity 29/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    30 ms
    Sleep
    5.5 h
    Steps
    7,098
    Resting HR
    70 bpm
    Daily log: GI score 50, nutritional resilience 41, adherence 76.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0329252%S1462
    P-0337842%S1059
    P-0303141%S16CR-01improved49
    P-0312041%S1461
    P-0320040%S1659
    P-0322139%S06GI-04no change64
    P-0337939%S12GI-04improved51
    P-0316038%S1863
    P-0334638%S17GI-04improved71
    P-0305237%S0344
    P-0347137%S0854
    P-0336336%S2062